Skip to main content
OSTEONIC Co., Ltd. logo

OSTEONIC Co., Ltd. — Investor Relations & Filings

Ticker · 226400 ISIN · KR7226400000 KO Manufacturing
Open in API
Filings indexed 292 across all filing types
Latest filing 2022-03-16 AGM Information
Country KR South Korea
Listing KO 226400

About OSTEONIC Co., Ltd.

http://osteonic.com/eng/

OSTEONIC Co., Ltd. is a medical device company specializing in the development and manufacturing of bone fixation and reconstructive implants. The company produces a comprehensive portfolio of products using both metallic and biodegradable composite materials. Its key product lines provide solutions for osteosynthesis and internal fixation in various surgical fields, including Cranio-Maxillofacial (CMF), trauma, sports medicine, spine, and neurosurgery. OSTEONIC operates its own mass production facilities and distributes its products to physicians and hospitals through a global sales network.

Recent filings

Filing Released Lang Actions
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a formal regulatory filing submitted by Osteonic regarding the scheduling of their Annual General Meeting (AGM) on a 'concentrated date' (a date when many companies hold their AGMs). It explains the reasons for this scheduling conflict and provides the meeting date. Since it is a regulatory notification regarding meeting logistics rather than the AGM presentation materials, the proxy statement, or the voting results, it falls under the general regulatory filing category.
2022-03-16 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Osteonic Co., Ltd. It details the meeting date, location, agenda items (such as approval of financial statements and director compensation), and includes management reports, business overviews, and financial statements. This document is a standard proxy statement/notice sent to shareholders to inform them of the upcoming Annual General Meeting (AGM) and to solicit their votes. In the context of the provided filing categories, this is classified as a Proxy Solicitation & Information Statement.
2022-03-16 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal announcement titled 'Audit Report Submission' (감사보고서 제출) filed by Osteonic. It provides a summary of the audit opinion (unqualified/proper), key financial data (assets, liabilities, equity, revenue, profit/loss), and auditor information. While it contains financial data, it is a regulatory disclosure announcing the completion and submission of the audit report to the exchange, rather than the full annual report itself. According to the 'Menu vs Meal' rule, this is a report publication announcement/regulatory filing regarding the audit status. FY 2021
2022-03-16 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Services Commission and Korea Exchange. It details the shareholding status, changes in ownership, and collateral agreements (stock-backed loans) of the major shareholder and special related parties of the company 'Osteonic'. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks significant ownership thresholds and changes in control.
2022-03-14 Korean
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Osteonic) regarding a correction (정정신고) to a previously submitted financial disclosure concerning a significant change in revenue or profit structure (30% or more). This type of filing is a standard regulatory disclosure required by the Korea Exchange (KRX) when financial results deviate significantly from previous periods or require correction. Since it is a specific regulatory announcement regarding financial performance metrics and corrections, it falls under the 'Regulatory Filings' category. FY 2021
2022-02-15 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Osteonic) announcing a significant change (over 15-30%) in revenue or profit structure. This is a standard mandatory disclosure filing in the Korean market (DART system) regarding financial performance updates. Since it provides specific financial figures and explains the reasons for the variance, it functions as an initial announcement of financial results, which falls under the 'Earnings Release' category. FY 2021
2022-02-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.